Citius Pharmaceuticals, Inc. (CTXR)
1.13
-0.03
(-2.59%)
USD |
NASDAQ |
Dec 12, 16:00
1.13
0.00 (0.00%)
After-Hours: 17:08
Citius Pharmaceuticals Cash from Investing (Quarterly): 0.00 for June 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Citius Oncology, Inc. | 0.00 |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.019M |
| Oragenics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.407M |
| Cash from Financing (Quarterly) | 11.47M |
| Free Cash Flow | -25.58M |
| Free Cash Flow Per Share (Quarterly) | -0.4912 |
| Free Cash Flow to Equity (Quarterly) | -6.356M |
| Free Cash Flow to Firm (Quarterly) | -5.229M |
| Free Cash Flow Yield | -263.8% |